Priorities of cancer research in Nepal
Priorities of cancer research in Nepal
OncoAlert and ecancer weekly roundup for August 17-23 2020
OncoAlert and ecancer weekly roundup for August 1-8 2020
CaRE2 Cancer Research Link© : Pancreatic Cancer Disparities featuring Prof Jose Trevino
CheckMate 459: Long-term survival outcomes with nivolumab versus sorafenib as first-line treatment in aHCC
Phase I/II results: First-line NALIRIFOX in patients with pancreatic ductal adenocarcinoma
Early safety from a trial of talimogene laherparepvec (T-VEC) injected into liver tumours plus pembrolizumab
Perioperative chemotherapy with mFOLFIRINOX vs gemcitabine/nab-paclitaxel for resectable pancreatic ductal adenocarcinoma
Checkpoint inhibitors for the treatment of advanced hepatocellular carcinoma
Highlights from ASCO 2020
The potential of KRAS inhibitors for non-small-cell lung cancer
NIVOREN: Nivolumab in a 'real world setting' for metastatic clear-cell renal cell carcinoma